However, the recent heightened social media attention on GLP-1 RAs, notably semaglutide and liraglutide, may have resulted in an imbalanced surge in reporting relative to other pharmaceuticals
Its important to remember that individual responses to semaglutide can vary, and success is measured not just by weight loss but also by improvements in overall health and well-being
According to Riccardo Perfetti and colleagues from Cedars-Sinai Medical Center, Division of Endocrinology in Los Angeles, California, continuous infusion of GLP-1 to both young and old rats demonstrated an up-regulation of pancreatic-duodenum homeobox-1 (PDX-1) expression in islets and total pancreas which is essential for pancreogenesis, pancreatic cell differentiation, and maturation
The controversial weight-loss drug Ozempic is a GLP-1
Visit www.fda.gov/medwatch or call 1-800-FDA-1088 .
Persistent gastrointestinal symptoms may cause dehydration, electrolyte imbalance, and kidney stress
